{"entity":{"type":"insider","cik":"0001291623","url":"/insider/0001291623","json_url":"/insider/0001291623.json","name":"Iversen Leslie L","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":5,"first":"2009-05-20","last":"2016-04-20","span_basis":"filed_date"},"name_variants":[{"name":"Iversen Leslie L","source":"filing","n_filings":5,"first_seen":"2009-05-20","last_seen":"2016-04-20"}],"transactions":[{"id":2613825,"accession":"0001415889-16-005582","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-16-005582","line_url":"/filing/0001415889-16-005582#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291623","owner_name":"Iversen Leslie L","owner_display_name":"Iversen Leslie L","owner_url":"/insider/0001291623","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33697.0,"shares_display":"33,697","price_per_share":33.5341,"price_display":"33.53","price_state":"stated","total_value":1129998.5677,"total_display":"1,129,998.57","total_whole":"1,129,999","shares_owned_after":36127.0,"shares_owned_after_display":"36,127","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-18","filed_date":"2016-04-20","scope":"insider"},{"id":8795856,"accession":"0001415889-15-003713","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001415889-15-003713","line_url":"/filing/0001415889-15-003713#line-5","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291623","owner_name":"Iversen Leslie L","owner_display_name":"Iversen Leslie L","owner_url":"/insider/0001291623","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":36.0109,"price_display":"36.01","price_state":"stated","total_value":1080327.0,"total_display":"1,080,327.00","total_whole":"1,080,327","shares_owned_after":36127.0,"shares_owned_after_display":"36,127","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-11","filed_date":"2015-11-13","scope":"insider"},{"id":6622991,"accession":"0001415889-14-000035","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-14-000035","line_url":"/filing/0001415889-14-000035#line-4","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291623","owner_name":"Iversen Leslie L","owner_display_name":"Iversen Leslie L","owner_url":"/insider/0001291623","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":25.0292,"price_display":"25.03","price_state":"stated","total_value":1501752.0,"total_display":"1,501,752.00","total_whole":"1,501,752","shares_owned_after":13500.0,"shares_owned_after_display":"13,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-02","filed_date":"2014-01-03","scope":"insider"},{"id":4614049,"accession":"0001415889-13-001821","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-13-001821","line_url":"/filing/0001415889-13-001821#line-4","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291623","owner_name":"Iversen Leslie L","owner_display_name":"Iversen Leslie L","owner_url":"/insider/0001291623","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":22.9245,"price_display":"22.92","price_state":"stated","total_value":1375470.0,"total_display":"1,375,470.00","total_whole":"1,375,470","shares_owned_after":13500.0,"shares_owned_after_display":"13,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-12","filed_date":"2013-09-13","scope":"insider"},{"id":5603051,"accession":"0001181431-09-026049","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-09-026049","line_url":"/filing/0001181431-09-026049#line-1","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291623","owner_name":"Iversen Leslie L","owner_display_name":"Iversen Leslie L","owner_url":"/insider/0001291623","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":1.65,"price_display":"1.65","price_state":"stated","total_value":4950.0,"total_display":"4,950.00","total_whole":"4,950","shares_owned_after":9000.0,"shares_owned_after_display":"9,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-18","filed_date":"2009-05-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001070494","name":"ACADIA PHARMACEUTICALS INC","url":"/issuer/0001070494","role":"Director","n_filings":5,"first_seen":"2009-05-20","last_seen":"2016-04-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001291623","retrieved_at":"2026-08-24T12:40:31+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}